SRSF12 and cancer: SRSF1 to SRSF12 have their specific binding region with distinct 6–10 nucleotide sequences.14 Therefore, dysregulation or overexpression of SRSFs can enable the events of splicing errors, and then the aberrant transcripts might be translatable into cancer related-proteins gaining oncogenic properties and potentially facilitating cancer progression.15